Medical Affairs and Scientific Communications Forum

For the past several years, Medical Affairs is increasingly recognized and have been held accountable to support critical success factors across the business to meet the needs of the medical community and the patients. With a growing number of challenges related to medical knowledge and information due to an information revolution in the digital space, policy changes, and evolving pipelines, a changing healthcare landscape is placing new demands on the life sciences industry. With the drive for greater demand of deep scientific information across the medical community and patient organizations, pharmaceutical companies are tackling these shifts through the expertise of Medical Affairs, specifically Medical Communications (MC) function. In the bio-pharmaceutical industry, the role of MC is to provide product-related medical information to healthcare professionals and consumers worldwide, as well as conveyance of knowledge to internal stakeholders and other relevant departments. With recent changes to regulatory and marketing practices, safety surveillance, and delivery of information conveyed to the medical communities, the traditional MC paradigm has shifted to a leadership function with decision-making entity, with anticipation of new and emerging responsibilities to enhance the work in Medical Affairs.